Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older.
- People who have been diagnosed with a type of skin cancer called non-melanoma skin cancer, confirmed by a tissue sample test, and are already scheduled to have the growth removed.
- People with any skin tone (the trial includes a range of skin tones based on a standard skin classification scale).
- People who are willing and able to follow the study procedures, as determined by the trial team.
- Women who could become pregnant must have a negative blood pregnancy test taken within 7 days before the study begins (this applies to women who have had at least one period in the past 12 months).
- People whose skin lesion or growth measures between 5 millimetres and 3 centimetres across.
Who may not be able to join:
- People under 18 years of age.
- People who are not able to give informed consent to participate.
- People with a known allergy to a medication called Ameluz.
- People who have conditions that cause unusual sensitivity to light, such as photosensitivity or photodermatoses.
- People with a serious underlying health condition that the investigator believes would make it unsafe or difficult to participate in the study.
- People with a known sensitivity to porphyrins or to any ingredient in Ameluz, including soya bean phosphatidylcholine.
- Women who are currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael Chapman, MD, Dartmouth
Phone: 603-653-2209
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detecting cutaneous malignant lesions using a non-invasive technique
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.